Care.fi secures Rs 7.5 Cr debt funding

IMT News Desk
IMT News Desk
· 2 min read

The funding will further expand the reach of RevNow by Care.fi to optimise hospital insurance claims and streamline revenue realisation

Care.fi, a pioneering healthcare-focussed fintech startup, has secured Rs 7.5 crore in debt capital from Vivriti Capital to accelerate its mission of revolutionising Revenue Cycle Management (RCM) for hospitals. With a strong emphasis on claims processing and financial automation, this funding will further expand the reach of RevNow by Care.fi, India’s most advanced AI-powered RCM platform designed to optimise hospital insurance claims and streamline revenue realisation.

This latest investment follows Care.fi’s previous funding rounds, which included Rs 8 crore in debt capital raised from Wint Wealth (Ambium Finserve) and Caspian, along with $2.5 million (around Rs 21 crore) in debt from Trifecta Capital and UC Inclusive Credit. In total, the group has raised approximately Rs 29 crore to date.

Sidak Singh, Co-founder, Care.fi, shared, “Since our inception, we have focussed on solving critical operational pain points in hospital revenue management. With RevNow, we are setting new benchmarks in claims processing efficiency. This latest funding will enable us to scale further, helping hospitals optimise financial workflows while ensuring better patient experiences. As the healthcare ecosystem grows, we aim to continue innovating and improving revenue realisation for providers.”

With its latest funding round, Care.fi aims to expand RevNow’s capabilities and integrate further with hospital information systems (HIS), electronic health records (EHR), and billing platforms. The company is also focussed on talent acquisition to strengthen its team and further drive innovation in RCM.

“Our primary focus is to enhance the reach and effectiveness of our claims processing solutions,” said Vikrant Agrawal, co-founder of Care.fi. “We have already facilitated insurance claims for over 50,000 patients, and this funding will enable us to further expand our presence in the healthcare sector, bringing more hospitals into the fold and improving financial efficiency across the industry.”

With an ambitious vision to become a $10 billion enterprise by 2030, Care.fi is redefining healthcare finance by bridging gaps in insurance claims processing, ensuring financial stability for hospitals, and enhancing the overall patient experience.

Read Next

Granules India posts Rs 13,879 million revenue from operations at Q3FY26
Finance
January 28, 2026

Granules India posts Rs 13,879 million revenue from operations at Q3FY26

Net debt stood at Rs 10,151 million and net debt to EBITDA at 0.91x Granules India has announced its financial results for the quarter ended December 31, 2025. Revenue from Operations of Q3FY26 stood at Rs 13,879 million, a growth of 22 per cent YoY driven by Finished Dosages (FD) segment in North America and […]
Article by: IMT News Desk
OneSource Pharma’s revenue down at Rs 2,903 million in Q3FY26
Finance
January 28, 2026

OneSource Pharma’s revenue down at Rs 2,903 million in Q3FY26

Impacted by delayed semaglutide approvals in Canada OneSource has posted the Q3FY26 results. Revenues were at Rs 2,903 million, down 26 per cent YoY, impacted by delayed semaglutide approvals in Canada. The EBITDA was at Rs 173 million, down 88 per cent YoY, due to lower revenue in the quarter and largely fixed cost base. […]
Article by: IMT News Desk
Syngene International’s Q3 revenue from operations dip 3% year-on-year to Rs 917 Cr
Finance
January 27, 2026

Syngene International’s Q3 revenue from operations dip 3% year-on-year to Rs 917 Cr

Reported revenue dips to Rs 932 crore in the same quarter Syngene International announced financial results for the third quarter of FY26. Peter Bains, Managing Director and CEO, Syngene International, said, “Our Q3 performance reflects the ongoing impact related to a single product from one of our large-molecule biologics clients. Outside of this factor, the […]
Article by: IMT News Desk
Sigachi Industries aims to increase revenue potential by Rs 250 cr commencing from Q427
Finance
January 27, 2026

Sigachi Industries aims to increase revenue potential by Rs 250 cr commencing from Q427

Sigachi’s entry into CF APIs positions the company in a structurally strong and innovation-led therapeutic segment with long-term demand visibility Sigachi Industries announced a significant milestone in its research and development pipeline with the successful advancement of a new Cystic Fibrosis (CF) Active Pharmaceutical Ingredients (APIs) combination comprising Vanzacaftor, Tezacaftor, and Deutivacaftor. The development marks […]
Article by: IMT News Desk